Treating saphenous vein graft lesions: Drug-eluting stents are not the answer!

Allison B. Hall, Emmanouil S Brilakis

Research output: Contribution to journalEditorial

Abstract

Saphenous vein graft (SVG) percutaneous coronary intervention carries high rates of acute (no reflow and periprocedural myocardial infarction) and long-term (restenosis and re-occlusion) complications. Long-term follow-up from the two largest trials of drug-eluting vs. bare metal stents in SVG lesions (The Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein graft Angioplasty and Is Drug-Eluting-Stenting Associated with Improved Results in Coronary Artery Bypass Grafts? Trial) definitely show no difference between the two stent types, suggesting that bare metal stents should be preferred given lower cost. Since SVG stenting remains associated with high failure rates, alternative treatment strategies, such as intervention of the corresponding native coronary artery lesions, may represent the future direction of the field.

Original languageEnglish (US)
Pages (from-to)E193-E194
JournalCatheterization and Cardiovascular Interventions
Volume93
Issue number3
DOIs
StatePublished - Feb 15 2019
Externally publishedYes

Fingerprint

Drug-Eluting Stents
Saphenous Vein
Stents
Transplants
Metals
Percutaneous Coronary Intervention
Angioplasty
Coronary Artery Bypass
Pharmaceutical Preparations
Coronary Vessels
Myocardial Infarction
Costs and Cost Analysis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Treating saphenous vein graft lesions : Drug-eluting stents are not the answer! / Hall, Allison B.; Brilakis, Emmanouil S.

In: Catheterization and Cardiovascular Interventions, Vol. 93, No. 3, 15.02.2019, p. E193-E194.

Research output: Contribution to journalEditorial

@article{047b733925a94b32bb6558ff76db5231,
title = "Treating saphenous vein graft lesions: Drug-eluting stents are not the answer!",
abstract = "Saphenous vein graft (SVG) percutaneous coronary intervention carries high rates of acute (no reflow and periprocedural myocardial infarction) and long-term (restenosis and re-occlusion) complications. Long-term follow-up from the two largest trials of drug-eluting vs. bare metal stents in SVG lesions (The Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein graft Angioplasty and Is Drug-Eluting-Stenting Associated with Improved Results in Coronary Artery Bypass Grafts? Trial) definitely show no difference between the two stent types, suggesting that bare metal stents should be preferred given lower cost. Since SVG stenting remains associated with high failure rates, alternative treatment strategies, such as intervention of the corresponding native coronary artery lesions, may represent the future direction of the field.",
author = "Hall, {Allison B.} and Brilakis, {Emmanouil S}",
year = "2019",
month = "2",
day = "15",
doi = "10.1002/ccd.28011",
language = "English (US)",
volume = "93",
pages = "E193--E194",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Treating saphenous vein graft lesions

T2 - Drug-eluting stents are not the answer!

AU - Hall, Allison B.

AU - Brilakis, Emmanouil S

PY - 2019/2/15

Y1 - 2019/2/15

N2 - Saphenous vein graft (SVG) percutaneous coronary intervention carries high rates of acute (no reflow and periprocedural myocardial infarction) and long-term (restenosis and re-occlusion) complications. Long-term follow-up from the two largest trials of drug-eluting vs. bare metal stents in SVG lesions (The Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein graft Angioplasty and Is Drug-Eluting-Stenting Associated with Improved Results in Coronary Artery Bypass Grafts? Trial) definitely show no difference between the two stent types, suggesting that bare metal stents should be preferred given lower cost. Since SVG stenting remains associated with high failure rates, alternative treatment strategies, such as intervention of the corresponding native coronary artery lesions, may represent the future direction of the field.

AB - Saphenous vein graft (SVG) percutaneous coronary intervention carries high rates of acute (no reflow and periprocedural myocardial infarction) and long-term (restenosis and re-occlusion) complications. Long-term follow-up from the two largest trials of drug-eluting vs. bare metal stents in SVG lesions (The Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein graft Angioplasty and Is Drug-Eluting-Stenting Associated with Improved Results in Coronary Artery Bypass Grafts? Trial) definitely show no difference between the two stent types, suggesting that bare metal stents should be preferred given lower cost. Since SVG stenting remains associated with high failure rates, alternative treatment strategies, such as intervention of the corresponding native coronary artery lesions, may represent the future direction of the field.

UR - http://www.scopus.com/inward/record.url?scp=85061590885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061590885&partnerID=8YFLogxK

U2 - 10.1002/ccd.28011

DO - 10.1002/ccd.28011

M3 - Editorial

C2 - 30770658

AN - SCOPUS:85061590885

VL - 93

SP - E193-E194

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 3

ER -